Elizabeth Bannet, MyOr's General Manager in Spain, presenting the MyorCare allergy prediction platform at BNEW 2023
Elizabeth Bannet, MyOr's General Manager in Spain, presenting the MyorCare allergy prediction platform at BNEW 2023
MyOr Diagnostics, dedicated to revolutionizing pediatric healthcare, is honored to have been awarded the BNEW Prize for Best New Health Startup.
BARCELONA, SPAIN, October 25, 2023 /EINPresswire.com/ -- MyOr Diagnostics, a groundbreaking health startup dedicated to revolutionizing pediatric healthcare, is honored to announce that it has been awarded the BNEW Prize for Best New Health Startup at the recent Barcelona New Economy Week (BNEW) event.
MyOr Diagnostics participated in BNEW, a prominent international business event, where it presented its lead product, MyorCare, to esteemed professionals, investors, and fellow innovators. The company's innovative approach to preventative health captured the attention of a distinguished audience and investors at the event, solidifying its position as an emerging leader in the industry. This prestigious recognition highlights the company's commitment to deliver cutting-edge solutions that have the potential to transform healthcare and improve lives.
During the event, MyOr was approached by other startups, industry leaders, and investors, further solidifying its place within the global health tech ecosystem. The exposure and connections established at BNEW will undoubtedly propel MyOr Diagnostics in its mission. The BNEW Prize for Best New Health Startup is a testament to MyOr’s unwavering dedication to enhancing food allergy and eczema prevention through state-of-the-art predictive analytics and AI technologies that provide accurate early detection and preventative strategies for a wide range of health conditions.
"MyOr Diagnostics is honored to receive the BNEW Prize for Best New Health Startup. This recognition motivates us to continue pushing the boundaries of health diagnostics, delivering groundbreaking solutions that have the potential to save lives and transform the healthcare industry," said Dr. Ariel Katz, Co-Founder and CEO of MyOr Diagnostics.
MyOr Diagnostics extends its sincere appreciation to the BNEW organizing committee, the esteemed judges, and all those who participated in the event. The company is excited to build on this momentum and continue its journey toward pioneering the future of healthcare Innovation.
About MyOr: MyOr Diagnostics is a forward-thinking health startup focused on revolutionizing healthcare diagnostics through predictive analytics, cutting-edge technology, and artificial intelligence. The company is committed to providing accurate early detection for several pediatric health conditions, making preventive health an accessible and personalized mode of care.
The company's vision is to create a world where early detection leads to lifelong prevention, accessible to all. By harnessing cutting-edge technologies, MyOr Diagnostics is dedicated to making this vision a reality, and the BNEW Prize is a significant stride in this endeavor.
For more information about MyOr Diagnostics and its innovative solutions, please visit www.myorcare.com or contact contact@myorcare.com.
Esther Levenson
MyOr Diagnostics
esther@myorcare.com
Visit us on social media:
LinkedIn
Instagram
